Can missing doses of montelukast (Singulair) cause hives?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hives After Missing Doses of Montelukast

No, developing hives after missing doses of montelukast is not a typical withdrawal effect, but rather may indicate that the medication was effectively controlling underlying mast cell-mediated symptoms that have now returned.

Mechanism and Role of Montelukast

Montelukast is a leukotriene receptor antagonist that works by blocking the action of leukotrienes, which are inflammatory mediators involved in allergic reactions. It is primarily used for:

  • Asthma management
  • Treatment of allergic rhinitis
  • Add-on therapy for urticaria (hives) that is resistant to antihistamines 1

Understanding the Relationship Between Montelukast and Hives

When analyzing the relationship between missed montelukast doses and hives, several key points emerge:

  1. Not a Direct Withdrawal Effect: The available guidelines do not list hives as a withdrawal symptom of montelukast. Unlike some medications, montelukast does not typically cause rebound effects when discontinued 1.

  2. Return of Underlying Symptoms: What appears to be happening is the return of symptoms that were being controlled by montelukast. According to the European and American guidelines, montelukast is often used as an add-on therapy for patients with urticaria who have inadequate response to antihistamines 2, 3.

  3. Effectiveness in Controlling Allergic Symptoms: Montelukast has demonstrated efficacy in controlling allergic symptoms in patients with both asthma and allergic rhinitis, with improvement reported in 86.5% of patients in clinical studies 4.

Management Algorithm for Patients Experiencing Hives After Missing Montelukast

Step 1: Resume Regular Dosing

  • Restart the regular montelukast regimen as prescribed (typically 10 mg once daily for adults) 1
  • Do not take extra doses to "catch up"

Step 2: Manage Acute Hives

  • For immediate relief of hives, use a second-generation H1 antihistamine (e.g., cetirizine, fexofenadine) 2
  • Consider increasing the antihistamine dose up to four times the standard dose if needed for symptom control 2, 3

Step 3: Evaluate for Potential Allergic Reaction to Montelukast

  • Although extremely rare, montelukast itself can cause angioedema in some patients 5
  • If hives consistently worsen after restarting montelukast (rather than improving), consult an allergist to evaluate for possible drug allergy

Special Considerations

Differentiating Between Symptom Return and True Drug Allergy

  • Symptom Return: Hives appear gradually after missing doses and improve with resumption of medication
  • True Drug Allergy: Hives or angioedema appear shortly after taking montelukast and worsen with continued use 5

Potential for Montelukast as Treatment for Hives

  • In some patients with severe chronic urticaria, montelukast has been shown to be beneficial as an add-on therapy when antihistamines alone are insufficient 3, 6
  • The EAACI/GA2LEN/EDF/WAO urticaria guideline recommends montelukast as a third-line treatment option for chronic urticaria 3

Common Pitfalls to Avoid

  1. Mistaking Return of Symptoms for Drug Withdrawal: The appearance of hives after stopping montelukast is more likely due to loss of the drug's therapeutic effect rather than a withdrawal syndrome.

  2. Overlooking Combination Therapy: For patients with recurrent hives, combination therapy with H1 antihistamines and montelukast may provide better control than either medication alone 2, 3.

  3. Failing to Recognize True Drug Allergy: While rare, true allergic reactions to montelukast can occur and should be evaluated by an allergist if suspected 5.

By understanding these principles, patients can better manage their medication regimen and minimize symptom recurrence when using montelukast for allergic conditions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Dermatological Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Possible montelukast-induced angioedema.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.